Insider Transactions in Q4 2023 at Bolt Biotherapeutics, Inc. (BOLT)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2023
|
William P. Quinn President, CEO and CFO |
BUY
Open market or private purchase
|
Direct |
7,500
+17.13%
|
$0
$0.95 P/Share
|
|
Dec 06
2023
|
William P. Quinn President, CEO and CFO |
BUY
Open market or private purchase
|
Direct |
2,500
+7.99%
|
$0
$0.78 P/Share
|
|
Nov 30
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
123,079
-5.6%
|
$0
$0.86 P/Share
|
|
Nov 29
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
25,805
-1.16%
|
$0
$0.91 P/Share
|
|
Nov 21
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
1,943
-0.09%
|
$0
$0.9 P/Share
|
|
Nov 21
2023
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,400
-0.49%
|
$0
$0.9 P/Share
|
|
Nov 20
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
31,257
-1.39%
|
$0
$0.92 P/Share
|
|
Nov 20
2023
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
54,700
-6.65%
|
$0
$0.92 P/Share
|
|
Nov 17
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
9,345
-0.41%
|
$0
$0.93 P/Share
|
|
Nov 17
2023
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,143
-2.65%
|
$0
$0.93 P/Share
|
|
Nov 17
2023
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,211
-0.41%
|
$0
$0.93 P/Share
|
|
Nov 16
2023
|
Edgar Engleman Director |
SELL
Open market or private sale
|
Indirect |
8,571
-0.38%
|
$0
$0.96 P/Share
|
|
Nov 16
2023
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
15,000
-1.68%
|
$0
$0.96 P/Share
|